Clinical Trial Update: Real-world Dapagliflozin Experience in Patients With Heart Failure in United Kingdom.

View source ↗

Summary

This report summarizes real-world outcomes of dapagliflozin in patients with heart failure in the United Kingdom from a completed AstraZeneca-sponsored study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Heart Failure | Status: COMPLETED